By Editor , 30 September 2026
AppZen Launches AI Agents to Automate Corporate Card Compliance

San Jose – September 30, 2026 -- AppZen has launched Autonomous Cards, an AI agent layer that automates compliance, monitoring and spend intelligence for enterprise corporate card programs, as commercial card volume in the U.S. hit $2.23 trillion in 2024, up 4.5% year-over-year, according to the Nilson Report.

By Editor , 30 September 2026
TrackVia Launches AI Layer IRIS, MCP Support, Rebuilt Android App

Denver – September 30, 2026 -- TrackVia has expanded its Field Operations Intelligence platform with a new artificial intelligence layer called IRIS, enterprise AI connectivity, a rebuilt Android application and a modernized web interface, targeting organizations managing complex field operations across construction, manufacturing, healthcare, hospitality, education and government.

By Editor , 30 September 2026
Novo Nordisk: Wegovy Pill Switch Study Shows 8.8 lb Loss in 3 Months

Plainsboro, New Jersey – – September 30, 2026 -- Adults with overweight or obesity who switched from injectable GLP-1 therapies to the oral Wegovy pill lost an average of 4.0 kg (8.8 lb) over three months, according to new real-world data from Novo Nordisk's OCTANE study presented at the 62nd Annual Meeting of the European Association for the Study of Diabetes in Milan on September 30, 2026.

By Editor , 30 September 2026
Ro, Novo Unveil First Real-World Data on Wegovy Pill Switch at EASD2026

New York – September 30, 2026 -- Direct-to-patient healthcare company Ro presented the first real-world evidence on Novo Nordisk's oral Wegovy pill at the EASD2026 meeting in Milan on September 30, based on outcomes from patients on its platform who switched from an injectable GLP-1.

By Editor , 30 September 2026
Astrocyte Raises $9.5M Series B as Concussion Drug Trial Completes Enrollment

Groton, Conn. – September 30, 2026 -- Astrocyte Pharmaceuticals Inc. has closed a $9.5 million Series B financing round to advance Phase 2 development of AST-004, its cerebroprotective therapy for concussion, traumatic brain injury (TBI) and stroke. The round brings total capital raised by the clinical-stage biotech, including grants, to $40 million.

By Editor , 30 September 2026
Paladone WeCool Names Matthew Lauderbach Product Development Director

Point Pleasant, N.J. – September 30, 2026 -- Paladone WeCool has appointed Matthew Lauderbach as Product Development Director, bringing more than 25 years of toy design experience to the company's US operations.

Lauderbach brings leadership experience from Fisher-Price, Spin Master and Just Play

Lauderbach's career spans leadership roles at Fisher-Price, Spin Master, Skip Hop and Just Play, with expertise covering concept creation, design management, engineering and commercialization.

By Editor , 30 September 2026
Halfpricesoft Adds Mid-Year YTD Import to ezPaycheck Software

Redmond, Wash. – September 30, 2026 -- Halfpricesoft.com has added mid-year payroll accommodation features to its ezPaycheck software, allowing accountants and small businesses to move payroll in-house at any point in the calendar year without losing historical data.